Antibodies against Gangliosides in Patients with SLE and Neurological Manifestations

Abstract

Pathogenesis of neuropsychiatric manifestations of systemic lupus erythematosus (SLE) has not been clearly defined, and the search for pathogenic mechanisms has focused on the importance of several autoantibodies. There is increasing evidence that antibodies against gangliosides may have a pathogenic role in some neurological disorders. The aim of the present study was to examine the association between antibodies against gangliosides and neuropsychiatric SLE. We found anti-type II ganglioside antibodies in two out of 32 patients with multiple sclerosis (6.25%) and in 10 out of 60 patients with SLE (16.6%); five of 17 patients with neurological abnormalities also had high levels of these antibodies (29.4%). Five of the 10 patients with SLE and positive antiganglioside antibody assays had only IgM antibodies, three had IgG antibodies and two had both isotypes. By chi-square analysis, the incidence of anti-type II ganglioside antibodies was not significantly higher in patients with symptoms related to the nervous system than in SLE patients without neurological involvement (P > 0.2). No clear correlation was found between antibodies against gangliosides and cardiolipin.

Keywords

Neuropsychiatric Lupus Demyelination

Get full access to this article

View all access options for this article.

References

Johnson RT , Richardson EP Jr. The neurological manifestations of systemic lupus erythematosus: a clinical-pathological study of 24 cases and review of the literature. Medicine (Baltimore) 1968; 47: 337-69.

Feinglass EJ , Arnett FC , Dorsch CA , Zizic TM , Stevens MB Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore) 1976; 55: 323-39.

Kaell AT , Shetty M. , Lee Bcp , Lockshin MD The diversity of neurologic events in systemic lupus erythematosus . Arch Neurol 1986; 43: 273-6.

Bluenstein HG , Williams GV , Steinberg AD Cerobrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med 1981; 70: 240-6.

Bonfa E. , Golombek SJ , Kaufman LD et al. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl JMed 1987; 317:265-71.

Harris EN , Gharavi AE , Asherson RA , Boey ML , Hughes Grv. Cerebral infarction in systemic lupus erythematosus: association with anticardiolipin antibodies. Clin Exp Rheum 1984; 2:47-51.

Asherson RA , Berksen Rhwm , Harris EN et al. Chorea in systemic lupus erythematosus and 'lupus-like' disease: association with antiphospholipid antibodies. Sem Arthritis Rheum 1987; 16: 253-9.

Ilyas AA , Willison HJ , Quarles RJ et al. Serum antibodies to gangliosides in Guillain-Barré syndrome . Ann Neurol 1988; 23:440-7.

Sindern E. , Stark E. , Haas J. , Steck AJ Serum antibodies to GM1 and GM3-gangliosides in systemic lupus erythematosus with chronic inflammatory demyelinating polyradiculoneuropathy. Acta Neurol Scand 1991; 83: 399-402.

10.

Pestronk A. , Adams RN , Clawson L. et al. Serum antibodies to GM1 gangliosides in amyotrophic lateral sclerosis. Neurology 1988; 38: 1457-61.

11.

Arnon R. , Crisp E. , Kelley R. , Ellison GW , Myers LW , Tourtellotte WW Anti-ganglioside antibodies in multiple sclerosis. J Neurol Sci 1980; 46: 179-86.

12.

Tan EM , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.

13.

Gharavi AE , Harris EN , Asherson RA , Hughes Grv. Anticardiolipin antibodies: isotype distribution and phospholipid specificity . Ann Rheum Dis 1987; 46: 1-6.

14.

Harris EN , Gharavi AE , Patel SP , Hughes Grv. Evaluation of the anticardiolipin antibody test: report of an international workshop held 4th April 1986. Clin Exp Immunol 1987; 68: 215-22.

15.

Sergott RC , Brown MJ , Silberberg DH , Lisak RP Antigalactocerebroside serum demyelinates optic nerve in vivo. J Neurol Sci 1984; 64:297-303.

16.

Rott GA , Roytta M. , Yu RK , Raine CS , Bornstein MB Antisera to different glycolipids induce myelin alterations in mouse spinal cord tissue cultures. Brain Res 1985 ; 339: 9-18.

17.

Irie H. , Yorita T. , Takahashi K.

Anti-galactocerebroside antibody in rabbits with experimental allergic neuritis. Japan

J Exp Med 1986; 56: 43-9.

18.

Hirano T. , Hashimoto H. , Shiokawa Y. et al. Antiglycolipid autoantibody detected in the sera from systemic lupus, erythematosus patients. J Clin Invest 1980; 66: 1437-40.

19.

Hirano T. , Miyahima H. , Taniguchi O et al. Anti asialo GM1 antibody detected in the patients' sera from systemic lupus erythematosus and Behcet's disease with neurological manifestations . Jpn J Med 1988; 27: 167-7 1.

20.

Costallat LT , de Oliveira RM , Santiago MB , Cossermelli W. Samara AM Neuropsychiatric manifestations of systemic lupus erythematosus: the value of anticardiolipin, antiganglioside, and antigalactocerebroside antibodies . Clin Rheumatol (Belgium) 1990; 9: 489-97.

21.

Endo T. , Scott DD , Stewart SS , Kundu SK , Marcus DM Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE . J Immunol 1984; 132: 1793-7.